Publications
Publications
The publications of the ESLHO networks can be found on the following pages:
The publications from 2023 and 2024 are also listed below.
EuroFlow publications
Phenotypic profiling of CD34+ cells by advanced flow cytometry improves the diagnosis of juvenile myelomonocytic leukemia
Bugarin C, Antolini L, Buracchi C, Matarraz S, Coliva TA, Van der Velden VH, Szczepanski T, Da Costa ES, Van der Sluijs A, Novakova M, Mejstrikova E, Nierkens S, De Mello FV, Fernandez P, Aanei C, Sędek Ł, Strocchio L, Masetti R, Sainati L, Philippé J, Valsecchi MG, Locatelli F, Van Dongen JJM, Biondi A, Orfao A, Gaipa G.
Haematologica 2024; 109: 521-32
Impact of the kinetics of circulating anti-CD19 CAR-T cells and their populations on the outcome of DLBCL patients
Martín-Martín L, Gutiérrez-Herrero S, Herrero-García M, Martín García-Sancho A, Yeguas A, Martín-López AÁ, López-Corral L, Pérez-López E, García-Blázquez M, Sánchez-Guijo F, Vidriales MB, Gaipa G; INCAR consortium; EuroFlow consortium; Orfao A.
Blood Cancer J. 2024; 14: 83.
Minimal residual disease assessment in B-cell precursor acute lymphoblastic leukemia by semi-automated identification of normal hematopoietic cells: a EuroFlow study
Verbeek MWC, Rodríguez BS, Sedek L, Laqua A, Buracchi C, Buysse M, Reiterová M, Oliveira E, Morf D, Oude Alink SR, Barrena S, Kohlscheen S, Nierkens S, Hofmans M, Fernandez P, de Costa ES, Mejstrikova E, Szczepanski T, Slota L, Brüggemann M, Gaipa G, Grigore G, van Dongen JJM, Orfao A, van der Velden VHJ.
Cytometry B Clin. Cytom. 2024; 106: 252-63.
The EuroFlow PIDOT external quality assurance scheme: enhancing laboratory performance evaluation in immunophenotyping of rare lymphoid immunodeficiencies
Neirinck J, Buysse M, Brdickova N, Perez-Andres M, De Vriendt C, Kerre T, Haerynck F, Bossuyt X, van Dongen JJM, Orfao A, Hofmans M, Bonroy C, Kalina T.
Clin Chem Lab Med. 2024; 63: 621-35.
Large T cell clones expressing immune checkpoints increase during multiple myeloma evolution and predict treatment resistance. Abstract book of 13th ESLHO Symposium: Application of multi-omics in hematological malignancies
Paiva B.
Lisbon 2024; 24-30
Performance of spectral flow cytometry and mass cytometry for the study of innate myeloid cell populations
van der Pan K, Khatri I, de Jager AL, Louis A, Kassem S, Naber BAE, de Laat IF, Hameetman M, Comans SET, Orfao A, van Dongen JJM, Díez P, Teodosio C.
Front Immunol 2023; 14: 1191992 Doi: 10.3389/fimmu. 2023.1191992.
Baseline immunophenotypic profile of bone marrow leukemia cells in acute myeloid leukemia with nucleophosmin-1 gene mutation: a EuroFlow study
Matarraz S, Leoz P, Yeguas-Bermejo A, van der Velden V, Bras AE, Sánchez Gallego JI, Lecrevisse Q, Ayala-Bueno R, Teodosio C, Criado I, González-González M, Flores-Montero J, Avendaño A, Vidriales MB, Chillón MC, González T, García-Sanz R, Prieto Conde MI, Villamor N, Magnano L, Colado E, Fernández P, Sonneveld E, Philippé J, Reiterová M, Caballero Berrocal JC, Diaz-Gálvez FJ, Ramos F, Dávila Valls J, Manjón Sánchez R, Solano Tovar J, Calvo X, García Alonso L, Arenillas L, Alonso S, Fonseca A, Quirós Caso C, van Dongen JJM, Orfao A.
Blood Cancer J. 2023 Sep 4;13(1):132. Doi: 10.1038/s41408-023-00909-4.
Technical alignment of standardized flow cytometry procedures among Cutaneous Lymphoma Working Groups (CLWGs) and EuroFlow centers: update on a Multicenter Study
De Bie F, van der Sluijs-Gelling A, Najidh S, de Haan S,Flores-Montero J, Orfao A, Dongen JJM, Almeida J, and Vermeer M.
European Journal of Cancer – Oral presentations: Clinical studies 1| Vol. 190, Suppl. 1, 113000, September 2023.
Minimal residual disease assessment in B-cell precursor acute lymphoblastic leukemia by semi-automated identification of normal hematopoietic cells: A EuroFlow study
Verbeek MWC, Rodríguez BS, Sedek L, Laqua A, Buracchi C, Buysse M, Reiterová M, Oliveira E, Morf D, Oude Alink SR, Barrena S, Kohlscheen S, Nierkens S, Hofmans M, Fernandez P, de Costa ES, Mejstrikova E, Szczepanski T, Slota L, Brüggemann M, Gaipa G, Grigore G, van Dongen JJM, Orfao A, van der Velden VHJ.
Cytometry B Clin Cytom. 2023 Sep 22. Doi: 10.1002/cyto.b.22143.
Automated EuroFlow approach for standardized in-depth dissection of human circulating B-cells and plasma cells
Delgado AH, Fluxa R, Perez-Andres M, Diks AM, van Gaans-van den Brink JAM, Barkoff AM, Blanco E, Torres-Valle A, Berkowska MA Grigor G, van Dongen JJM, and Orfao A on behalf of The PERISCOPE Consortium.
Frontiers in Immunology Vol 14 – 2023. Doi: 10.3389/fimmu.2023.1268686.
EuroMRD publications
Analysis of measurable residual disease by IG/TR gene rearrangements: quality assurance and updated EuroMRD guidelines
van der Velden VHJ, Dombrink I, Alten J, Cazzaniga G, Clappier E, Drandi D, Eckert C, Fronkova E, Hancock J, Kotrova M, Kraemer R, Montonen M, Pfeifer H, Pott C, Raff T, Trautmann H, Cavé H, Schäfer BW, van Dongen JJM, Trka J, Brüggemann M; EuroMRD Consortium.
Leukemia. 2024; 38: 1315-1322 May 14
The gray area of RQ-PCR-based measurable residual disease: subdividing the “positive, below quantitative range” category
Kotrova M, Fronkova E, Svaton M, Drandi D, Schön F, Hoogeveen P, Hancock J, Skotnicova A, Schilhabel A, Eckert C, Clappier E, Cazzaniga G, Schäfer BW, van Dongen JJM, Ritgen M, Pott C, van der Velden VHJ, Trka J, Brüggemann M.
Leukemia. 2024; 38: 1617-1620
EuroClonality publications
LymphoID: development of an integrated approach combining EuroFlow and EuroClonality-NGS validated assays for the diagnosis of lymphoproliferative disorders
Stewart JP, Nakjang S, Gonzalez D, on behalf of the EuroClonality-NGS Working Group.
In: van Dongen JJM et al., eds. Abstract book of 13th ESLHO Symposium: Multi-omics approaches for diagnosis and monitoring of hematological malignancies. Lisbon: 2024: 50-53.
Combined targeted proteomics, immunomics and genetics for early detection of lymphoma
Kolijn PM.
In: van Dongen JJM et al., eds. Abstract book of 13th ESLHO Symposium: Multi-omics approaches for diagnosis and monitoring of hematological malignancies. Lisbon: 2024: 54-59.
A novel next-generation sequencing capture-based strategy to report somatic hypermutation status using genomic regions downstream to immunoglobulin rearrangements
McCafferty N, Stewart JP, Darzentas N, Gazdova J, Catherwood M, Stamatopoulos K, Langerak AW, Gonzalez D.
Haematologica. 2023;108:1313-1321 (online publication 29 Dec 2022).
Read the clonotype: Next-generation sequencing-based lymphocyte clonality analysis and perspectives for application in pathology
Groenen PJTA, van den Brand M, Kroeze LI, Amir AL, Hebeda KM.
Front Oncol. 2023 Feb 8;13:1107171.
A novel next-generation sequencing capture-based strategy to report somatic hypermutation status using genomic regions downstream to immunoglobulin rearrangements
McCafferty N, Stewart JP, Darzentas N, Gazdova J, Catherwood M, Stamatopoulos K, Langerak AW, Gonzalez D.
Haematologica. 2023 May 1;108:1313-1321.
Clonotype definitions for immunogenetic studies: proposals from the EuroClonality NGS Working Group Leukemia
Sofou E, Vlachonikola E, Zaragoza-Infante L, Brüggemann M, Darzentas N, Groenen PJTA, Hummel M, Macintyre EA, Psomopoulos F, Davi F, Langerak AW, Stamatopoulos K.
2023 Aug 37;1750-1752.
EuroClonality-NGS Recommendations for Evaluation of B-Cell Clonality Analysis by Next-Generation Sequencing: A Structured Approach with the DEPART Algorithm
Van den Brand M, Möbs M, Otto F, Kroeze LI, Gonzalez de Castro D, Stamatopoulos K, Davi F, Bravetti C, Kolijn PM, Vlachonikola E, Stewart JP, Pott C, Hummel M, Darzentas N, Langerak AW, Fend F, Groenen PJTA.
J Mol Diagn. 2023;25:729-739.